Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Cardiomyopathy Dr.mirdamadi Cardiologist, fellowship of echocardiograpy Definition: • Group of diseases that primarily affect the heart muscle and are not the result of congenital, acquired, valvular, hypertensive , coronary arterial or pericardial abnormalities Classification: Dilated primary myocardial involvement Restrictive secondary myocardial involvement: Hypertrophic ( infective, Metabolic, Connective tissue disorders Infiltration, toxin, peripartum) Dilated cardiomyopathy (DCM) • 1/3 of CHF is due to DCM • LV and/or RV systolic function is impaired leading to progressive cardiac dilation • No cause detected in many cases, but familial (1/4-1/3 of cases) or secondary cause like infectious, metabolic or toxic agents present. • Reversible form may be found with alcohol abuse, pregnancy, thyroid disease, cocaine use and chronic uncontrolled tachycardia. Clinical features • symptoms of left and right sided CHF. • some patients have LV dilation for months or even years before becoming symptomatic • vague chest pain (typical angina is unusual and suggestive of IHD) • syncope due to arrhythmias • systemic embolism Physical examination • Narrow pulse pressure and elevated JVP in advanced disease • S3 • S4 • MR • TR Laboratory examination • CXR : cardiomegaly , pulmonary congestion • ECG : Sinus tachycardia or AF , Ventricular • • arrhythmias, Non specific changes Echocardiography : LV dilation , systolic dysfunction Angiography : to exclude IHD • Endomyocardial biopsy : is not necessary in idiopathic or familial DCM but may be helpful in the recognition of secondary CMP like amyloidosis and myocarditis • most patient has progressive course • patients > 55 years die within 4 years of the onset of symptoms • Spontaneous improvement in about onequarter of patient • death is due to progressive HF or ventricular arrhythmia or brady arrhythmia Alcoholic cardiomyopathy • large quantities (>90g/d) of alcohol over many years cause DCM • Risk of developing CMP is partially genetically • patient with severe CHF have a poor prognosis (< 1/4 of such patients survive 3 years) • Second presentation of alcoholic cardiotoxicity is recurrent supraventricular or ventricular tachyarrhythmia’s • Holiday heart syndrome: AF, Atrial flutter or frequeut PVC after a drinking binge. Peripartum cardiomyopathy • Cardiac dilation and CHF may develop during the last trimester of pregnancy or within 6 months of delivery. • Mortality rate is 10%. • Patient who recover from peripartum CMP should be encouraged to avoid further pregnancy . Drugs • A variety of drugs may damage the • • • • myocardium acutely (myocarditis) or they may lead to chronic damage (like DCM) Anthracycline derivatives : Doxorubicin cardiotoxicity may occur acutely but more commonly develops 3 months after the last dose. TCA – antidepressants, phenothiazines , lithium Cocaine abuse (SCD , myocarditis , DCM, acute MI ) Arrhythmogenic right ventricular cardiomyopathy / Dysphasia (ARVC/D) • ARVD is a familial CMP with progressive fibrofatty replacement of the RV and to a much lesser degree LV. • Patients may present by RV failure or ventricular tachycardia Others • Neuromuscular disease • Tako – tsubo (stress) CMP • Non compaction CMP Hypertrophic cardiomyopathy • characterized by LV hypertrophy without obvious cause • It is 1 in 500 of general population • two features af HCM : asymmetric LV hypertrophy , Dynamic LVOT obstruction • There is a bizarre and disorganized arrangement of myocytes with variable degree of fibrosis. • About a half of patients have a positive family history compatible with autosomal dominant transmission Normal and HCM cellular arrengement • Screening by echocardiography of first- degree relatives between the age 12 and 20 should be done every 12-24 months unless diagnosis evaluated by genetic testing Clinical features • Clinical course is variable , from asymptomatic to SCD • SCD frequently occur in children and young adult during or after physical exertion. • HCM is the most common cause of SCD in young competitive athletes • Other symptom : dyspnea , syncope , angina and fatigue. Physical examination • Double or triple apical precordial impulse • Fourth heart sound • Harsh , diamond – shaped systolic murmur in LSB due to LVOT obstruction • Holosystolic and blowing systolic murmur at apex due to MR Hemodynamic • Obstruction in LVOT is dynamic (not fixed) and is due to narrowing of the LVOT by systolic anterior motion (SAM) of mitral valve against the hypertrophied septum. Hemodynamic • Three mechanisms are involved dynamic obstruction : • 1) increased LV contractility (exercise) • 2) decreased ventricular preload (strain phase of valsalva maneuver , standing ) • 3) decreased ventricular after load Squatting , sustained handgrip position with leg raising , expansion of volume in pregnancy decreased obstruction Laboratory evaluation • ECG : LVH and deep broad Q waves (mistake as a MI) • CXR : Cardiomegaly • Echocardiography : septal hypertrophy ( septum>=1.3 times of posterior wall ) • SAM of mitral valve with MR. Apical HCM • Apical hypertrophy • Giant negative T wave on the ECG • Spade – shaped LV cavity Management • Competitive sports and very strenuous activities should be proscribed • dehydration should be avoided. • B- blockers ameliorate angina and syncope in1/3- 1/4 of patients • Varapamil and diltiazem may reduce the stiffness of LV • Amiodaron reduced risk of SCD and arrhythmia • Digitalis,diuretics,nitrates, dihydropyridine calcium blockers, vasodilators and B- agonists are best avoided. • Surgical myotomy / myectomy of septum and ethanol injections into the septal artey are the invasive treatment. • ICD should be considered in high- risk patients Restrictive cardiomyopthy • Hallmark of the RCM is abnormal diastole function. • Myocardial fibrosis,hypertrophy or infiltration caused rigid LV walls • Amyloidosis, hemochromatosis, glycogen storage disease, endomyocardial fibrosis, sarcoidosis, hypereosinophilic disease, sceleroderma, following mediastinal irradiation • Inability of the ventricles to fill, caused decrease cardiac out put • exercise intolerance and dyspnea • elevated systemic venous pressure cause edema ascitis and elevated JVP Laboratory examinations • in infiltrative disease ECG often shows low – voltage, nonspecific ST/T change and various arrhythmias. • Echocardiography , CT and MRI showed thickened LV walls with normal LV systolic function and dilated atria. Differentiation of RCM from Constrictive pericarditis important. • Management is usually disappointing except for hemochromatosis and fabry’s disease. Myocarditis • myocarditis is most commonly the result of infectious process, frequently complicated by autoimmunity. • myocarditis may also result from hypersensitivity to drugs (TCA , antibiotics,antipsychotics) or may be caused by irradiation, chemicals or physical agents. • Most common cause is viruses especially coxsakievirus B adenovirus hepatitis C and HIV • Patients with viral myocarditis may give a history of upper respiratory febrile illness or a flu like syndrome , and viral nasopharyngitis or tonsillitis may be evident. Clinical manifestation • clinical spectrum ranges from an asymptomatic state to fulminant condition with arrhythmias, acute CHF and death. • sometime myocarditis simulates an acute coronary syndrome ( chest pain, ECG change and elevated troponin level ) but typically in patients younger than those with coronary atherosclerosis. • Viral myocarditis is most often self-limited and without sequelae but sometime may progress to a chronic from and to DCM.